Managers / Q2 2022 · view latest →
MORGAN JESS S & CO INC
CIK 0001133335 · C/O JESS S MORGAN & CO INC, 5900 WILSHIRE BLVD STE 2300, LOS ANGELES, CA, 90036 · 3236342400
Summary
Morgan Jess S & Co Inc reported $96M in U.S.-listed holdings across 37 positions for Q2 2022.
Its largest position, IYJ, represents 13.5% of the portfolio.
Compared with Q1 2022, the fund opened 4 new positions and exited 10.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 50.8% · $49M
- ETP · 48.0% · $46M
- Closed-End Fund · 1.2% · $1M
Quarter-over-Quarter Changes full breakdown →
vs Q1 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| DBCINVESCO DB COMMDY INDX TRCK | NEW | +209.3K | 209.3K | +$6M | $6M |
| IEOISHARES TR | NEW | +39.0K | 39.0K | +$3M | $3M |
| PPAINVESCO EXCHANGE TRADED FD T | NEW | +42.4K | 42.4K | +$3M | $3M |
| DIREXION SHS ETF TR | NEW | +29.7K | 29.7K | +$200,000 | $200,000 |
| XLFSELECT SECTOR SPDR TR | SOLD OUT | −125.6K | 0 | −$5M | $0 |
| KRESPDR SER TR | SOLD OUT | −68.5K | 0 | −$5M | $0 |
| AMZNAMAZON COM INC | SOLD OUT | −1.3K | 0 | −$4M | $0 |
| BACBK OF AMERICA CORP | SOLD OUT | −100.8K | 0 | −$4M | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2022
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | IYJISHARES TR | US INDUSTRIALS · ISHARES SEMICDTR · US OIL GS EX ETF · RUSSELL 3000 ETF · EXPANDED TECH | 13.46% | $13M | 102.0K |
| 2 | DBCINVESCO DB COMMDY INDX TRCKhistory → | UNIT | 5.78% | $6M | 209.3K |
| 3 | QQQINVESCO QQQ TRhistory → | UNIT SER 1 | 5.25% | $5M | 18.1K |
| 4 | FTGCFIRST TR EXCHANGE TRAD FD VIhistory → | FST TR GLB FD | 5.13% | $5M | 184.8K |
| 5 | UNHUNITEDHEALTH GROUP INChistory → | COM | 4.96% | $5M | 9.3K |
| 6 | AAPLAPPLE INChistory → | COM | 4.59% | $4M | 32.4K |
| 7 | JNJJOHNSON & JOHNSONhistory → | COM | 4.59% | $4M | 24.9K |
| 8 | PEPPEPSICO INChistory → | COM | 4.47% | $4M | 25.8K |
| 9 | XLKSELECT SECTOR SPDR TR | TECHNOLOGY · SBI HEALTHCARE · SBI CONS STPLS | 4.46% | $4M | 39.6K |
| 10 | AXSMAXSOME THERAPEUTICS INChistory → | COM | 4.17% | $4M | 104.9K |
| 11 | XBISPDR SER TRhistory → | S&P BIOTECH | 3.85% | $4M | 50.0K |
| 12 | TMOTHERMO FISHER SCIENTIFIC INChistory → | COM | 3.81% | $4M | 6.8K |
| 13 | NVCRNOVOCURE LTDhistory → | ORD SHS | 3.48% | $3M | 48.3K |
| 14 | HONHONEYWELL INTL INChistory → | COM | 3.47% | $3M | 19.2K |
| 15 | INTUINTUIThistory → | COM | 3.44% | $3M | 8.6K |
| 16 | VCRVANGUARD WORLD FDShistory → | CONSUM DIS ETF | 3.38% | $3M | 14.3K |
| 17 | AVGOBROADCOM INChistory → | COM | 3.11% | $3M | 6.2K |
| 18 | PPAINVESCO EXCHANGE TRADED FD Thistory → | AEROSPACE DEFN | 3.08% | $3M | 42.4K |
| 19 | ADBEADOBE SYSTEMS INCORPORATEDhistory → | COM | 3.05% | $3M | 8.0K |
| 20 | FDNFIRST TR EXCHANGE-TRADED FDhistory → | DJ INTERNT IDX | 2.67% | $3M | 20.3K |
| 21 | AGENUS INC | COM NEW | 2.65% | $3M | 1.32M |
| 22 | ORMPORAMED PHARMACEUTICALS INChistory → | COM NEW | 1.50% | $1M | 315.3K |
| 23 | CHECKPOINT THERAPEUTICS INC | COM | 1.21% | $1M | 1.14M |
| 24 | QQQXNUVEEN NASDAQ 100 DYNAMIC OVhistory → | COM SHS | 1.17% | $1M | 51.9K |
| 25 | NVDANVIDIA CORPORATION | COM | 0.96% | $930,000 | 6.1K |
| 26 | MSFTMICROSOFT CORP | COM | 0.81% | $786,000 | 3.1K |
| 27 | VTIVANGUARD INDEX FDS | TOTAL STK MKT | 0.78% | $754,000 | 4.0K |
| 28 | INTCINTEL CORP | COM | 0.23% | $224,000 | 6.0K |
| 29 | CLENE INC | COMMON STOCK | 0.23% | $220,000 | 87.3K |
| 30 | DIREXION SHS ETF TR | SP BIOTCH BL NEW | 0.21% | $200,000 | 29.7K |
| 31 | LCTXLINEAGE CELL THERAPEUTICS IN | COM | 0.03% | $32,000 | 20.0K |
Filing History
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.